Ratajczak Andrzej, Kościński Tomasz, Banasiewicz Tomasz, Lange-Ratajczak Małgorzata, Hermann Jacek, Bobkiewicz Adam, Drews Michał
Pol Przegl Chir. 2013 Jul;85(7):377-80. doi: 10.2478/pjs-2013-0057.
Mesh biomaterials have become the standard in the treatment of hernias, regardless the location. In addition to the obvious advantages of the methods based on implantable biomaterials, one should be aware of the possible complications, such as their migration to the abdominal organs.
The study group comprised patients operated at the Department of General, Gastroenterological Oncology, and Plastic Surgery during the period between 2008 and 2011, due to hernia surgery with mesh implantation. We also analysed the number of patients operated, due to complications of mesh migration during the same period.
368 patients were subject to mesh implantation, due to hernias during the period between 2008 and 2011. Three patients underwent surgery because of symptomatic migration of the mesh (ileus, fistula).
The frequency of mesh migration is difficult to determine because of the different criteria of migration, observation period, and other factors. In patients after mesh implantation the potential migration of the biomaterial should be considered in case of unclear or acute abdominal symptoms.
无论疝气位于何处,网状生物材料已成为疝气治疗的标准方法。除了基于可植入生物材料的方法具有明显优势外,还应意识到可能出现的并发症,例如它们向腹部器官的迁移。
研究组包括2008年至2011年期间在普通外科、胃肠肿瘤外科和整形外科接受疝气手术并植入网片的患者。我们还分析了同期因网片迁移并发症而接受手术的患者数量。
2008年至2011年期间,368例患者因疝气接受了网片植入。3例患者因网片出现症状性迁移(肠梗阻、瘘管)而接受手术。
由于迁移标准、观察期和其他因素不同,网片迁移的频率难以确定。在植入网片的患者中,若出现不明原因或急性腹部症状,应考虑生物材料潜在的迁移情况。